vs
Side-by-side financial comparison of Laird Superfood, Inc. (LSF) and Pulmonx Corp (LUNG). Click either name above to swap in a different company.
Pulmonx Corp is the larger business by last-quarter revenue ($20.6M vs $13.3M, roughly 1.5× Laird Superfood, Inc.). Laird Superfood, Inc. runs the higher net margin — -13.2% vs -66.3%, a 53.2% gap on every dollar of revenue. On growth, Laird Superfood, Inc. posted the faster year-over-year revenue change (15.0% vs -8.7%). Over the past eight quarters, Laird Superfood, Inc.'s revenue compounded faster (16.1% CAGR vs -0.5%).
Laird Superfood, Inc. develops, manufactures and sells a portfolio of plant-based functional superfood products, including premium coffee creamers, hydration blends, nutritional supplements, and plant-powered snacks. It serves health-conscious consumers through direct-to-consumer e-commerce platforms and offline retail partners, mainly operating in the North American market with a focus on sustainably sourced clean ingredients.
Pulmonx Corp is a global medical tech firm focused on interventional pulmonology solutions. It develops minimally invasive endobronchial valves to treat severe COPD and emphysema, with products sold across North America, Europe, and Asia-Pacific for patients with advanced lung conditions.
LSF vs LUNG — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $13.3M | $20.6M |
| Net Profit | $-1.8M | $-13.7M |
| Gross Margin | 34.1% | 77.9% |
| Operating Margin | -13.5% | -40.9% |
| Net Margin | -13.2% | -66.3% |
| Revenue YoY | 15.0% | -8.7% |
| Net Profit YoY | -341.4% | 5.5% |
| EPS (diluted) | — | $-0.33 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $20.6M | ||
| Q4 25 | $13.3M | $22.6M | ||
| Q3 25 | $12.9M | $21.5M | ||
| Q2 25 | $12.0M | $23.9M | ||
| Q1 25 | $11.7M | $22.5M | ||
| Q4 24 | $11.6M | $23.8M | ||
| Q3 24 | $11.8M | $20.4M | ||
| Q2 24 | $10.0M | $20.8M |
| Q1 26 | — | $-13.7M | ||
| Q4 25 | $-1.8M | $-10.4M | ||
| Q3 25 | $-975.1K | $-14.0M | ||
| Q2 25 | $-362.2K | $-15.2M | ||
| Q1 25 | $-156.2K | $-14.4M | ||
| Q4 24 | $-398.4K | $-13.2M | ||
| Q3 24 | $-166.1K | $-14.1M | ||
| Q2 24 | $-239.1K | $-15.3M |
| Q1 26 | — | 77.9% | ||
| Q4 25 | 34.1% | 77.6% | ||
| Q3 25 | 36.5% | 74.7% | ||
| Q2 25 | 39.9% | 72.1% | ||
| Q1 25 | 41.9% | 72.5% | ||
| Q4 24 | 38.6% | 74.0% | ||
| Q3 24 | 43.0% | 73.7% | ||
| Q2 24 | 41.8% | 73.7% |
| Q1 26 | — | -40.9% | ||
| Q4 25 | -13.5% | -43.8% | ||
| Q3 25 | -7.7% | -66.9% | ||
| Q2 25 | -3.3% | -62.0% | ||
| Q1 25 | -1.9% | -64.6% | ||
| Q4 24 | -4.1% | -56.5% | ||
| Q3 24 | -2.3% | -69.3% | ||
| Q2 24 | -3.4% | -75.2% |
| Q1 26 | — | -66.3% | ||
| Q4 25 | -13.2% | -46.1% | ||
| Q3 25 | -7.6% | -64.9% | ||
| Q2 25 | -3.0% | -63.6% | ||
| Q1 25 | -1.3% | -64.1% | ||
| Q4 24 | -3.4% | -55.4% | ||
| Q3 24 | -1.4% | -69.4% | ||
| Q2 24 | -2.4% | -73.7% |
| Q1 26 | — | $-0.33 | ||
| Q4 25 | — | $-0.25 | ||
| Q3 25 | — | $-0.34 | ||
| Q2 25 | — | $-0.38 | ||
| Q1 25 | — | $-0.36 | ||
| Q4 24 | — | $-0.33 | ||
| Q3 24 | — | $-0.36 | ||
| Q2 24 | — | $-0.39 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $5.1M | $61.6M |
| Total DebtLower is stronger | — | $37.3M |
| Stockholders' EquityBook value | $11.5M | $45.8M |
| Total Assets | $19.2M | $120.0M |
| Debt / EquityLower = less leverage | — | 0.82× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $61.6M | ||
| Q4 25 | $5.1M | $69.8M | ||
| Q3 25 | $5.1M | $76.5M | ||
| Q2 25 | $3.9M | $75.5M | ||
| Q1 25 | $7.0M | $74.6M | ||
| Q4 24 | $8.3M | $70.9M | ||
| Q3 24 | $7.9M | $63.3M | ||
| Q2 24 | $7.6M | $63.5M |
| Q1 26 | — | $37.3M | ||
| Q4 25 | — | $37.1M | ||
| Q3 25 | — | $37.1M | ||
| Q2 25 | — | $37.1M | ||
| Q1 25 | — | $37.2M | ||
| Q4 24 | — | $37.2M | ||
| Q3 24 | — | $37.2M | ||
| Q2 24 | — | $37.2M |
| Q1 26 | — | $45.8M | ||
| Q4 25 | $11.5M | $54.1M | ||
| Q3 25 | $12.8M | $60.0M | ||
| Q2 25 | $13.4M | $69.1M | ||
| Q1 25 | $13.3M | $77.7M | ||
| Q4 24 | $13.2M | $85.8M | ||
| Q3 24 | $13.1M | $93.9M | ||
| Q2 24 | $12.6M | $101.2M |
| Q1 26 | — | $120.0M | ||
| Q4 25 | $19.2M | $129.3M | ||
| Q3 25 | $18.9M | $138.3M | ||
| Q2 25 | $20.4M | $147.2M | ||
| Q1 25 | $21.5M | $150.7M | ||
| Q4 24 | $19.3M | $162.8M | ||
| Q3 24 | $18.8M | $167.4M | ||
| Q2 24 | $18.0M | $172.6M |
| Q1 26 | — | 0.82× | ||
| Q4 25 | — | 0.69× | ||
| Q3 25 | — | 0.62× | ||
| Q2 25 | — | 0.54× | ||
| Q1 25 | — | 0.48× | ||
| Q4 24 | — | 0.43× | ||
| Q3 24 | — | 0.40× | ||
| Q2 24 | — | 0.37× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $68.4K | — |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $68.4K | $-7.1M | ||
| Q3 25 | $1.2M | $-8.2M | ||
| Q2 25 | $-2.8M | $-3.9M | ||
| Q1 25 | $-1.3M | $-13.2M | ||
| Q4 24 | $339.2K | $-6.7M | ||
| Q3 24 | $305.8K | $-7.2M | ||
| Q2 24 | $642.7K | $-5.8M |
| Q1 26 | — | — | ||
| Q4 25 | — | $-7.1M | ||
| Q3 25 | — | $-8.3M | ||
| Q2 25 | — | $-4.0M | ||
| Q1 25 | — | $-13.5M | ||
| Q4 24 | — | $-6.8M | ||
| Q3 24 | — | $-7.7M | ||
| Q2 24 | — | $-6.2M |
| Q1 26 | — | — | ||
| Q4 25 | — | -31.4% | ||
| Q3 25 | — | -38.4% | ||
| Q2 25 | — | -16.6% | ||
| Q1 25 | — | -60.0% | ||
| Q4 24 | — | -28.8% | ||
| Q3 24 | — | -37.6% | ||
| Q2 24 | — | -30.0% |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.1% | ||
| Q3 25 | — | 0.4% | ||
| Q2 25 | — | 0.2% | ||
| Q1 25 | — | 1.3% | ||
| Q4 24 | — | 0.5% | ||
| Q3 24 | — | 2.0% | ||
| Q2 24 | — | 2.3% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LSF
| Wholesale | $7.0M | 52% |
| Coffee Tea And Hot Chocolate Products | $4.4M | 33% |
| Hydration And Beverage Enhancing Supplements | $1.6M | 12% |
| Other | $352.6K | 3% |
LUNG
Segment breakdown not available.
